Inhibikase Therapeutics
IKT
IKT
14 hedge funds and large institutions have $10.6M invested in Inhibikase Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.96M | |
| 2 | +$1.32M | |
| 3 | +$1.18M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$933K |
| 5 |
AC
Antara Capital
New York
|
+$700K |
Top Sellers
| 1 | -$107K | |
| 2 | -$67K | |
| 3 | -$12K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |